- First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute
March 20, 2019 9:00 pm
- Transgene: A Positive 2018, Moving Ahead with a Strong Portfolio
March 20, 2019 5:45 pm
- Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai March 20, 2019 4:40 pm
- MichBio Announces 7th Annual “Michigan Biosciences Day at the Capitol,” Seeks Participants March 20, 2019 4:34 pm
- Pharma Logistics Announces Partnership with PDM Healthcare March 20, 2019 4:30 pm
- Latin America Pharmaceutical Excipients Market Outlook to 2024 by Functionality and Country – Includes Profiles on Ashland, BASF, DowDuPont, Roquette, and Kerry Group – ResearchAndMarkets.com March 20, 2019 4:24 pm
- Promega Joins Fight against Colorectal Cancer with $50,000 Donation March 20, 2019 3:43 pm
- Nimbus Therapeutics Grows Scientific Team, Adding Leaders in Biology and Preclinical Development
March 20, 2019 1:00 pm
- Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare Diseases
March 20, 2019 1:00 pm
- Sage Therapeutics gets approval for Zulresso, first new drug to treat postpartum depression
March 20, 2019 12:55 pm
- Global $490.11 Mn Flow Cytometry Market Growth, Trends, and Forecasts 2019-2024 – ResearchAndMarkets.com March 20, 2019 12:47 pm
- Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
March 20, 2019 12:45 pm
My Pharmaceutical
Consequences of microbead: What makes microbeads problematic
In the world of great discoveries that cure or add a positive element to our everyday existence, the invention of microbeads hasn’t proven to be one of them. Not alone in its quick rise to popularity and slow journey to extinction, the microbead is just one of numerous products rushed to market before its long term effects are uncovered.
